PharmGenEd™ Psychiatry I: Depression

submitted by: KuoOffice

This webinar was presented on Thursday, October 21, 2010 by Dr. Vicki Ellingrod. Dr. Ellingrod discusses select pharmacogenomic effects in patients treated with antidepressant medications.

PharmGenEd™: Psychiatry II: Antipsychotics

submitted by: KuoOffice

This webinar was presented on Tuesday, August 24, 2010 by Dr. Jeffrey R. Bishop. Dr. Bishop discusses select pharmacogenomic effects in patients treated with antipsychotic medications.

A Generalist's Guide to Treating Patients With Depression With an Emphasis on Using Side Effects to Tailor Antidepressant Ther

submitted by: mcgheekkm

Dr. J. Michael Bostwick, Professor of Psychiatry at Mayo Clinic in Rochester, MN, discusses his article on a generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapy.

Neuropathic Pain Neurodegenerative Disease

submitted by: alex01

Dr. Remi Quirion (McGill University, Montreal, Quebec, Canada) described enhancement of the effects of pain-related peptides by PGE2 . This finding suggests a new, possible complimentary approach to the therapy of pain. Qurion also discussed anti-Alzheimer effect of polyphenols. This effect appears to be due not due to their antioxidant activity only. Quirion suggested the existence of membrane protein than binds polyphenols.

Drug Discovery for Alzheimer's Disease

submitted by: alex01

Gregory Rose from PharmExperts.com interviews J. Buccafusco (Medical College of Georgia, Augusta, GA) about his development of new anti-Altzheimer drugs, designed to act by multiple mechanisms to improve congnition. Desensitization of nicotinic receptors is one of the novel approaches proposed by Buccafusco. Three of his compounds are currently in advanced preclinical evaluation.